SGIP1: A Protein Involved in SH3 Tyrosine Kinase and Disease Development

Target Name: SGIP1

NCBI ID: G84251

SGIP1

Other Name(s): SH3GL interacting endocytic adaptor 1 | Endophilin-3-interacting protein | endophilin-3-interacting protein | SGIP1_HUMAN | SH3-containing GRB2-like protein 3-interacting protein 1 (isoform 1) | SH3 domain GRB2 like endophilin interacting protein 1 | SH3GL interacting endocytic adaptor 1, transcript variant 1 | SGIP1 variant 1 | SH3-containing GRB2-like protein 3-interacting protein 1

SGIP1: A Protein Involved in SH3 Tyrosine Kinase and Disease Development

SGIP1 (SH3GL interacting endocytic adapter 1) is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of the Sh3- tyrosine kinase signaling pathway, which is involved in many cellular processes, including cell growth, differentiation , and survival. Unfortunately, SGIP1 has also been implicated in the development and progression of many diseases, including cancer. As a result, SGIP1 has become a promising drug target and a focus of research in the scientific community.

SGIP1 was first identified in the late 1990s as a protein that interacted with the SH3 tyrosine kinase. The SH3 tyrosine kinase is a transmembrane protein that is involved in many cellular signaling pathways, including the regulation of cell growth, differentiation, and survival. SGIP1 was shown to play a role in the regulation of SH3 tyrosine kinase activity by interacting with its catalytic subunit.

SGIP1 is a 21-kDa protein that is composed of a N-terminal region, a catalytic region, and a C-terminal region. The N-terminal region contains a putative N-acyl transferyl group (NATG) domain, which is known to be involved in protein-protein interactions. The catalytic region contains a unique Rossmann-fold, which is a structural motif that is involved in the regulation of protein function. The C-terminal region contains a glycine residue, which is involved in the regulation of SGIP1 stability and function.

SGIP1 has been shown to play a role in many cellular processes, including the regulation of cell growth, differentiation, and survival. For example, SGIP1 was shown to be involved in the regulation of cell proliferation in various tissues, including breast, colon, and ovarian cancer cells. It was also shown to be involved in the regulation of cell survival in tissues that are naturally resistant to cell death, such as the brain and heart.

In addition to its role in cellular signaling pathways, SGIP1 has also been shown to play a role in the development and progression of many diseases. For example, SGIP1 has been shown to be involved in the development and progression of cancer, including breast, colon , and ovarian cancer. It has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

As a result, SGIP1 has become a promising drug target and a focus of research in the scientific community. Many studies have been conducted to determine the role of SGIP1 in various cellular processes and to identify potential drug targets. In addition, several companies have developed compounds that target SGIP1, with the goal of using these compounds as therapeutic agents for a variety of diseases.

One of the challenges in studying SGIP1 is its complex structure and the limited information that is available about its function. However, research into SGIP1 is ongoing and is likely to continue to be a focus of research in the scientific community. As more studies are conducted , it is likely that the role of SGIP1 in cellular signaling pathways and disease development will become better understood.

In conclusion, SGIP1 is a protein that has been shown to play a role in many cellular processes and has been implicated in the development and progression of many diseases. As a result, it has become a promising drug target and a focus of research in the scientific community. Further studies are needed to fully understand its role in cellular signaling pathways and disease development.

Protein Name: SH3GL Interacting Endocytic Adaptor 1

Functions: May function in clathrin-mediated endocytosis. Has both a membrane binding/tubulating activity and the ability to recruit proteins essential to the formation of functional clathrin-coated pits. Has a preference for membranes enriched in phosphatidylserine and phosphoinositides and is required for the endocytosis of the transferrin receptor. May also bind tubulin. May play a role in the regulation of energy homeostasis

The "SGIP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SGIP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets